Esperion Therapeutics (ESPR) Q2 2026 Earnings

May 8Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.21
-0.15
-0.08
-0.02

Details

Expected EPS
-0.037143
Actual EPS
-0.1
Surprise EPS
-0.06
Surprise Percent
-169.23%

Description

⁨Esperion Therapeutics⁩ (⁦ESPR⁩) has reported earnings of ⁦-0.1⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts